iiinova — where your digital self keeps evolving

Sanchit Sharma

@sanchitsharma2188.bsky.social

Hepatologist . Interests in portal hypertension and hepatic hemodynamics. Loves everything about liver, football and cricket. # YNWA

Posts Replies Media

Reposted by Sanchit Sharma

Pierre Gholam MD @livermd.bsky.social · 15/10/2025

Effective rx for severe Alcohol Associated Steatohepatitis #ASH is the greatest unmet need in #hepatology It fills hospital beds & kills people in their prime Yet… A cursory look shows >40 clinical stage ph2/3 #MASH studies vs (maybe) 3 for ASH We need to get our priorities straight… #liversky

011

Sanchit Sharma @sanchitsharma2188.bsky.social · 06/08/2025

Some evidence on role of Simvastatin and Carvedilol in patients after variceal🩸. Stage of cirrhosis and right combination may b the 🔑 for statins in PHTN #LiverSky. @easlnews.bsky.social @bavenocoop.bsky.social @amcollegegastro.bsky.social @aasldnews.bsky.social journals.lww.com/ajg/abstract...

051

Reposted by Sanchit Sharma

The Baveno Cooperation: an EASL Consortium @bavenocoop.bsky.social · 09/05/2025

🔗 Full paper: doi.org/10.1111/apt.... 📝 Editorial by @reibergerthomas.bsky.social and Benedikt Simbrunner: onlinelibrary.wiley.com/doi/epdf/10.... #LiverTwitter

doi.org

Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis (CALIBRE Trial)

There is no evidence of a difference between carvedilol 12.5 mg daily and VBL in the primary prevention of variceal bleeding in patients with cirrhosis and medium-to large-sized oesophageal varices. ....

095